- Home
- DAC vs OLMA Comparison
DAC vs OLMA Comparison
Compare DAC & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAC | OLMA |
|---|---|---|
| Founded | 1972 | 2006 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2006 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DAC | OLMA |
|---|---|---|
| Price | $107.03 | $14.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $105.00 | $41.13 |
| AVG Volume (30 Days) | 80.7K | ★ 1.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.30% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $65.40 | $2.86 |
| 52 Week High | $118.83 | $36.26 |
Technical Indicators
Market Signals| Indicator | DAC | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 44.12 | 20.04 |
| Support Level | $91.64 | $4.35 |
| Resistance Level | $118.83 | $27.38 |
| Average True Range (ATR) | 3.63 | 1.35 |
| MACD | -1.04 | -0.94 |
| Stochastic Oscillator | 4.78 | 3.20 |
Price Performance
Historical ComparisonAbout DAC Danaos Corporation
Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include, HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia-Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.